+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06511063

Study of HIV Antiviral Drugs Truvada and Selzentry to Reduce Symptoms in Adults with Long Covid

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-03-13

90

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether two repurposed HIV antiviral drugs can reduce symptoms in adults living with Long Covid. This Phase 2 trial compares the effects of Truvada tenofovir disoproxilemtricitabine, Selzentry, and a placebo in people who have had Long Covid symptoms for at least six months after confirmed or suspected COVID-19 infection. The study is sponsored by the Icahn School of Medicine at Mount Sinai and aims to understand if targeting viral infections or reactivations can help relieve Long Covid symptom burden. Participants will be randomly assigned to one of three groups one group will take Truvada once daily along with a placebo capsule, another group will take Selzentry twice daily, and the third group will take placebo capsules twice daily. All treatments are taken orally for 90 days. The trial uses a quadruple-blind design to ensure unbiased results. Participants will be monitored during the treatment period and followed up to day 180. Throughout the study, participants will complete several health questionnaires and assessments at screening, day 60, day 90, and day 180. These include the EuroQol 5-Dimension 5-Level Visual Analogue Scale for quality of life, symptom severity scales, fatigue and sleep quality questionnaires, and mental health assessments. Researchers will track symptom changes, quality of life, and cognitive function while monitoring safety. The total participation time spans approximately six months, allowing for observation of treatment effects and symptom progression.

CONDITIONS

Brief Title

Antiviral Clinical Trial for Long Covid-19

Research Team

D

David Putrino, PhD, PT

M

Mackenzie Doerstling, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here